Nobiretic (Hydrochlorothiazide, Nebivolol)

Nobiretic, a combination antihypertensive, is used to manage elevated blood pressure.

• Hypertension: lowers systolic and diastolic pressure in patients with primary hypertension.
• Essential hypertension: helps achieve target blood pressure when monotherapy is insufficient.
• Secondary hypertension: may be employed as part of combination therapy for hypertension secondary to renal or endocrine disorders.

• Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of water and electrolytes, which reduces plasma volume. Nebivolol selectively blocks β1‑adrenergic receptors, decreasing heart rate and contractility, while also stimulating endothelial nitric‑oxide release, leading to vasodilation. The combined actions result in lowered systemic vascular resistance and blood pressure.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Headache: mild to moderate pain often occurring early in therapy.
• Increased urination: due to the diuretic component.
• Fatigue: general tiredness or weakness.

Serious or Rare Side Effects

• Severe electrolyte imbalance: such as hypokalemia or hyponatremia.
• Acute gout attacks: sudden joint pain due to uric acid changes.
• Significant hypotension: dangerously low blood pressure.
• Bronchospasm: airway constriction, particularly in susceptible individuals.
• Allergic reactions: including rash, angioedema, or anaphylaxis.

Before initiating therapy, consider the following precautions:

• Monitor electrolytes: regularly check serum potassium and sodium levels.
• Assess renal function: evaluate kidney function prior to and during treatment.
• Caution in diabetes: monitor blood glucose as the drug may affect glycemic control.
• Avoid abrupt discontinuation: sudden stop can cause rebound hypertension.
• Store at room temperature: keep in the original pack, protect from moisture and light.

Nobiretic may interact with several medicines.

Major Interactions (Avoid)

• NSAIDs: may reduce diuretic efficacy and increase renal risk.
• Other antihypertensives: can cause excessive hypotension.
• Lithium: increased lithium levels and toxicity.
• Potassium‑sparing diuretics: risk of hyperkalemia.
• CYP2D6 inhibitors: elevate nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: enhanced renal effects, monitor kidney function.
• Antidiabetic drugs: possible alteration of glucose control.
• Warfarin: may affect INR, require monitoring.
• Alcohol: can increase dizziness and hypotensive effects.
• Antidepressants (SSRIs): may augment blood pressure lowering.